THE DAY, IN CONTEXTPolaris InsightsAn AI-powered comprehensive news portal

POLARIS INSIGHTS

Amgen vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?

Choosing between Amgen (NASDAQ: AMGN) and Bristol Myers Squibb (NYSE: BMY) requires balancing growth potential against value-oriented income.

Read the full account of the story

More from the Markets desk

More from Markets · Back to Polaris Insights